Business

Endexx Announces Contract with Impulse Health to Target Multibillion-Dollar Automation Market

Endexx Announces Contract with Impulse Health to Target Multibillion-Dollar Automation Market.

articleEndexx Corp.January 29, 20185/company/endexx-corp/news/endexx-announces-contract-with-impulse-health-to-target-multibillion-dollar-automation-market
Endexx Announces Contract with Impulse Health to Target Multibillion-Dollar Automation Market

About this update from Endexx Corp.

[{"type":"text","content":"\n\n Company Extends Footprint to Over 20,000 Pharmacies and Retailers Nationwide\n\n \n \n \n \n \n \n \n \n \n \n \n Autospense Tambor 750\n \n \n \n \n \n \n \n \n\n CAVE CREEK, AZ , Jan. 29, 2018 (GLOBE NEWSWIRE) -- Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce that it has secured a contract with Impulse Health to bring retail products into its AutoSpense™ Technology dispensing solutions. According to Research and Markets, the global pharmacy automation market is expected to reach $9.55 billion by 2022. Research and Markets predicts that retail automation worldwide is expected to reach $18.99 billion by 2023. There is a growing global trend toward utilizing automation in numerous industries, especially in retail and pharmacies, for the purpose of reducing costs and errors and increasing safety measures. With this collaboration, Endexx will partner with Impulse Health to offer a new customer focused solution to over 20,000 retail and pharmacy locations nationwide utilizing Endexx’s AutoSpense™ industrial-grade automated inventory control and dispensing solutions. Now, customers will be able to automate the retail process and have access to inventory and be able to pick up products as well as prescriptions after hours. In addition, the retail stores and pharmacies will have the ability to provide additional value-added service, increase productivity and sales, improve security and reduce operating costs. Dustin Sullivan, VP Business Development with Impulse Health, comments, “We are excited to bring AutoSpense™ to the marketplace. This creates a new standard for customer access to restricted or regulated products. AutoSpense™ delivers a new solution for our retail partners that protects consumer privacy, improves tracking of regulated products and reduces overall product shrink.” “Impulse Health has a highly talented and successful management team with a strong depth of experience in both pharmacy and retail, and we see a complementary fit for their products within our AutoSpense™ solution,” said Todd Davis, CEO of Endexx. “This collaboration represents a significant milestone in advancing our technology forward.  This contr...

More updates from Endexx Corp.